Vitruvias Pharmaceuticals completes Series A round

The Auburn-based pharmaceutical has completed a multimillion-dollar investment round.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.